packageFezolinetant

fezolinetant

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Fezolinetant is used to treat hot flashes associated with menopause. It is authorised in the European Union and is a relatively recently approved medicine.

Summary written by glm-5.3-flash from Wikidata Q27269455 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:fezolinetant
ATC codes:G02CX06
DrugBank:DB15669
PubChem CID:117604931
Wikidata:Q27269455
formula:C16H15FN6OS
molar mass:358.395 g/mol (PubChem CID 117604931)
logP:1.6 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown